Laparoscopic and robotic-assisted D2 surgery for gastric cancer: a reality in Europe?

摘要

The high rate of early gastric cancer (EGC) diagnosis, approximately 50% of all cases, in Japan and Korea has resulted in the rapid development, validation, and standardization of minimally invasive surgery for the treatment of early disease. Rigorous criteria have been established by the Japanese Association for Gastric Cancer for decision-making on endoscopic submucosal dissection (ESD) and laparoscopic surgery. Technical advances have revolutionized surgical oncology during the past two decades [1].